World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 92 11148 10475 448 423 509 38421

Daniel Gaudet publications per year

The chart shows the history of publications by Daniel Gaudet between 1982 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Daniel Gaudet published across 44 years, from 1982 to 2025, averaging 14.3 papers a year. Output peaked at 47 publications in 2025. 90 of the 629 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1982 to 2025. Vertical axis: number of publications, 0 to 47. Peak 47 publications in 2025. 1982: 1 publication 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 2 publications 1990: 0 publications 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 4 publications 1995: 3 publications 1996: 0 publications 1997: 10 publications 1998: 5 publications 1999: 10 publications 2000: 18 publications 2001: 11 publications 2002: 10 publications 2003: 7 publications 2004: 13 publications 2005: 14 publications 2006: 14 publications 2007: 19 publications 2008: 11 publications 2009: 16 publications 2010: 23 publications 2011: 10 publications 2012: 26 publications 2013: 33 publications 2014: 30 publications 2015: 33 publications 2016: 26 publications 2017: 28 publications 2018: 28 publications 2019: 19 publications 2020: 40 publications 2021: 25 publications 2022: 20 publications 2023: 30 publications 2024: 43 publications 2025: 47 publications
1982 2025

629 publications in total across all disciplines

View publications per year as a table
Daniel Gaudet: publications per year, 1982 to 2025
Year Publications
1982 1
1983 0
1984 0
1985 0
1986 0
1987 0
1988 0
1989 2
1990 0
1991 0
1992 0
1993 0
1994 4
1995 3
1996 0
1997 10
1998 5
1999 10
2000 18
2001 11
2002 10
2003 7
2004 13
2005 14
2006 14
2007 19
2008 11
2009 16
2010 23
2011 10
2012 26
2013 33
2014 30
2015 33
2016 26
2017 28
2018 28
2019 19
2020 40
2021 25
2022 20
2023 30
2024 43
2025 47
Total 629
Download as CSV

Daniel Gaudet publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Daniel Gaudet sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 501–520 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 509 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617 509
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Daniel Gaudet D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel Gaudet sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839 92
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Daniel Gaudet is affiliated with the University of Montreal in Canada and has contributed extensively to research in medicine and biochemistry, genetics, and molecular biology. Their work spans various subfields including surgery, cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, cancer research, and molecular biology.

The scientist's research primarily focuses on lipid metabolism and disorders, with significant attention to lipoproteins and cardiovascular health. Other notable topics in their body of work include the interrelation of cancer, lipids, and metabolism; diabetes, cardiovascular risks, and lipoproteins; hyperglycemia and glycemic control in critically ill and hospitalized patients; liver disease diagnosis and treatment; and pharmaceutical economics and policy.

Daniel Gaudet has frequently published in several key medical journals, including:

  • Atherosclerosis
  • Journal of Clinical Lipidology
  • Circulation
  • New England Journal of Medicine
  • Journal of the American College of Cardiology

Collaborations are a notable part of Gaudet's academic career. Frequent co-authors include Diane Brisson, Robert A. Hegele, Christie M. Ballantyne, Frederick J. Raal, and Robert S. Rosenson, reflecting interdisciplinary cooperation among researchers in cardiovascular and metabolic disease.

Noteworthy recent publications associated with Daniel Gaudet include:

  • Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society, 2021, European Heart Journal
  • Evinacumab for Homozygous Familial Hypercholesterolemia, 2020, New England Journal of Medicine
  • Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease, 2022, New England Journal of Medicine
  • Evinacumab in Patients with Refractory Hypercholesterolemia, 2020, New England Journal of Medicine
  • Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial, 2021, The Lancet Respiratory Medicine

Best Publications

  • The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

    David Altshuler;Joel N. Hirschhorn;Joel N. Hirschhorn;Joel N. Hirschhorn;Mia Klannemark;Cecilia M. Lindgren;Cecilia M. Lindgren

  • Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia

    John J.P. Kastelein;Fatima Akdim;Erik S.G. Stroes;Aeilko H. Zwinderman

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

    Isabelle Lemieux;Agnès Pascot;Charles Couillard;Benoı̂t Lamarche

  • Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

    Frederick J Raal;Raul D Santos;Dirk J Blom;A David Marais

  • Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease.

    John D. Rioux;Mark J. Daly;Mark S. Silverberg;Kerstin Lindblad

  • PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2) : a randomised, double-blind, placebo-controlled trial

    Frederick J Raal;Evan A Stein;Robert Dufour;Traci Turner

  • Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

    Evan A Stein;Dan Gipe;Jean Bergeron;Daniel Gaudet

  • Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.

    Marina Cuchel;Emma A. Meagher;Hendrik Du Toit Theron;Dirk J. Blom;Dirk J. Blom

  • Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

    Alexandra-Chloé Villani;Mathieu Lemire;Geneviève Fortin;Edouard Louis

  • Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.

    Claude Gagné;Daniel Gaudet;Eric Bruckert

  • Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

    Daniel Gaudet;Veronica J. Alexander;Brenda F. Baker;Diane Brisson

  • Evinacumab for Homozygous Familial Hypercholesterolemia

    Frederick J. Raal;Robert S. Rosenson;Laurens F. Reeskamp;G. Kees Hovingh

  • Targeting APOC3 in the Familial Chylomicronemia Syndrome

    Daniel Gaudet;Diane Brisson;Karine Tremblay;Veronica J. Alexander

  • Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society

    Henry N Ginsberg;Chris J Packard;M John Chapman;Jan Borén

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome

    Joseph L Witztum;Daniel Gaudet;Steven D Freedman;Veronica J Alexander

  • Efficacy and long term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open label trial

    D Gaudet;J Méthot;S Déry;D Brisson

  • Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.

    Ulrich Laufs;Maciej Banach;G. B. John Mancini;Daniel Gaudet

  • Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia Results of a Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety as Add-On Therapy in Patients With Coronary Artery Disease

    Evan A. Stein;Robert Dufour;Claude Gagne;Daniel Gaudet

  • Haplotype Structure and Genotype-Phenotype Correlations of the Sulfonylurea Receptor and the Islet ATP-Sensitive Potassium Channel Gene Region

    Jose C. Florez;Noël Burtt;Paul I.W. de Bakker;Peter Almgren

Frequent Co-Authors

Tomáš Paus
Tomáš Paus University of Toronto
Thomas J. Hudson
Thomas J. Hudson Ontario Institute for Cancer Research
Jean-Pierre Després
Jean-Pierre Després Université Laval
Michal Abrahamowicz
Michal Abrahamowicz McGill University
Gabriel Leonard
Gabriel Leonard Montreal Neurological Institute and Hospital
Robert A. Hegele
Robert A. Hegele University of Western Ontario
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam
Pavel Hamet
Pavel Hamet University of Montreal
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Joel N. Hirschhorn
Joel N. Hirschhorn Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open alternative career pathways in the health sector. For students who want to work in healthcare but don't wish to become physicians, nursing is a popular option. Many programs now cater to diverse backgrounds. For example, online direct entry MSN programs for non-nurses provide a fast track for individuals holding a non-nursing bachelor’s degree to transition into advanced nursing roles.

Admission standards also vary. Some schools offer direct entry nursing programs with less competitive requirements, making them more accessible for applicants. Additionally, those interested in supporting healthcare operations rather than providing hands-on care can consider studying at one of the best medical billing and coding schools online, which often offer financial aid.

For applicants concerned about admission exams, there are even nursing school that does not require teas test, simplifying the process further. These diverse online routes provide flexible, achievable alternatives for building a healthcare career in the USA.

Best Scientists Citing Daniel Gaudet

Trending Scientists

Recently Published Articles